To include your compound in the COVID-19 Resource Center, submit it here.

How CMS plans to retool payments for antibiotics

CMS updated its payment system last week to make it easier for antibiotic companies to turn a profit, but the changes improve an already-established pathway rather than implementing an innovative subscription-based model as called for by former FDA Commissioner Scott Gottlieb and being evaluated by

Read the full 454 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE